Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: Budesonide, glycopyrronium, and formoterol fumarate
Study Title: A study to learn how much of a combination of budesonide, glycopyrronium, and formoterol fumarate reaches the lungs in participants with chronic obstructive pulmonary disease
Protocol Number: D5980C00020

Thank you!

Thank you to the participants who took part in the clinical study for the study drug combination of budesonide, glycopyrronium, and formoterol fumarate. AstraZeneca sponsored this study and thinks it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results. If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.